Seeking Alpha

NPSP

NPS Pharmaceuticals, Inc.

5/26/2012, 5:13 PM ET

Business Intelligence
Transcripts
Events
Key Developments

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

187 people get NPSP articles and Market Currents by email alert.

Get email alerts on NPSP »

NPSP Market Currents more »

May 3 NPS Pharmaceuticals (NPSP): Q1 EPS of -$0.12 misses by $0.01. Revenue of $22.2M (-3% Y/Y) misses by $1.7M. (PR)
2 Comments
[Earnings, Healthcare]

NPSP in Focus more »

NPS Pharmaceuticals: The Next Orphan-Drug Powerhouse?

Jason Boyce • Tue, Apr 24 • 4 Comments
NPS Pharmaceuticals Gets Good News (Finally)

Bryce Istvan • Mon, Nov 7, 2011 • 1 Comment
Forward Looking Trial Results Should Help NPS Pharmaceuticals Bounce Back

M. E. Garza • Mon, Nov 7, 2011 • 2 Comments
Cancer Risks May Delay, But Shouldn't Derail, The Gattex Train

Stephen Simpson • Tue, Nov 1, 2011 • 1 Comment
NPS Pharmaceuticals' Sell-Off Was Overdone

Bryce Istvan • Tue, Nov 1, 2011 • 2 Comments

NPSP Related Articles more »

3 Biotech Stocks Reporting Earnings Next Week With A Decreasing Number Of Shorts

Kapitall • Tue, Feb 7 • Comment!
2 High Risk/High Reward Biotechs That Could Double

Bret Jensen • Mon, Jan 23 • 2 Comments
Insiders Love These 18 High Growth Stocks

Kapitall • Wed, Jan 18 • Comment!
10 Biotech Stocks With Strong Corporate Governance

Kapitall • Wed, Jan 18 • 2 Comments
11 Biotech Bets For 2012

James Stocklasar Thomas Jr. • Thu, Jan 12 • 4 Comments
3 Biotech Stocks To Buy, 2 Avoid This Year

Dividend Kings • Tue, Jan 10 • 2 Comments
January Worthies: 5 Small-Caps Worthy Of Their January Bounce

Arsene Lupin • Thu, Jan 5 • 2 Comments
Short-Sellers Expect These 14 Biotechs To Outperform

Kapitall • Thu, Jan 5 • Comment!
4 Overbought Biotechs For Potential Short-Term Shorts

Kinetic Investments • Tue, Jan 3 • 44 Comments
Top 10 Biotech Stocks Loved By Hedge Funds

Insider Monkey • Thu, Dec 29, 2011 • Comment!

NPSP News more »

Movers & Shakers: Monday’s biggest gaining and declining stocks

at MarketWatch.com (Oct 31, 2011)
Movers & Shakers: Monday’s biggest gaining and declining stocks

at MarketWatch.com (Jan 31, 2011)
Biotech Stocks: Depomed, NPS lead drug stocks higher

at MarketWatch.com (Jan 31, 2011)

NPSP Press Releases and Filings more »

Digestive Disease Week Presentations Support Therapeutic Potential for Gattex (teduglutide) as Novel Treatment for Adult Short Bowel Syndrome

Business Wire (Mon, 8:00AM)
NPS Pharmaceuticals Reports First Quarter 2012 Financial Results

Business Wire (May 3, 2012)
NPS Pharmaceuticals Reports Four Additional Patients Achieve Independence from Parenteral Support in STEPS 2 Study of Gattex® in Adult Short Bowel Syndrome

Business Wire (May 3, 2012)
NPS Pharmaceuticals to Report First Quarter 2012 Financial Results

Business Wire (Apr 27, 2012)
NPS Pharmaceuticals Among 100 Best Places to Work in New Jersey

Business Wire (Apr 26, 2012)

NPSP Latest Transcript more »

NPSP Pharmaceuticals CEO Discusses Q3 2010 - Earnings Call Transcript

Tue, Nov 2, 2010
Popular searches: amgen, npsp, nucynta, nycomed, Teva.

Earlier NPSP transcripts

NPSP Cramer more »

Currently, there are no Cramer articles on NPSP.

NPSP Instablog posts more »

January Worthies Ran Hard And Fast : But Now It's February

Fri, Feb 17 • Arsene Lupin • Comment!
January Worthies : Performance To Date And Recommendations

Mon, Jan 23 • Arsene Lupin • Comment!
New Biotech Milestones and Database Updates for July 26, 2010

Mon, Jul 26, 2010 • Andrew Nava • Comment!
Biotech Events: June Medical and Investor Conferences (Jefferies List)

Fri, Jun 4, 2010 • Andrew Nava • Comment!

Write a post on NPSP

NPSP StockTalks

NPSP vs. ETF Alternatives

Company Description

Currently, there's no company description for NPSP.

Sector: Healthcare

Industry: Biotechnology

Country: United States